Anagenex Announces First Programs in Synthetic Lethal Oncology Franchise
17 Jul 2024 //
BUSINESSWIRE
Anagenex Expands Leadership Team with Appointment of Adrian Schreyer as CTO
04 Mar 2024 //
BUSINESSWIRE
Anagenex and Nimbus Announce a Multi-Target Collaboration
18 Dec 2023 //
BUSINESSWIRE
Anagenex Appointed Robert Forrester and Isaac Ro
16 Nov 2023 //
BUSINESSWIRE
Anagenex Appoints Ryan Kruger as CSO
16 Nov 2022 //
BUSINESSWIRE
Anagenex Appoints Pharma R&D Veteran Ryan Kruger as Chief Scientific Officer
16 Nov 2022 //
BUSINESSWIRE